CB Pharma Acquisition (CNLMU) Priced

Biotech-focused blank check company backed by Coronado Biosciences.

SPAC - SPAC-Health Care

IPO Performance
Latest Trade $10.30 +10.29 (+102900.0%)
First Day Return 0.0%
Return from IPO -99.9%
 
CB Pharma Acquisition IPO News more
  • .
IPO Data
IPO File Date 10/23/2014
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 4.0
Deal Size ($mm) 40
 
IPO Data
IPO Date 12/12/2014
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 4.0
Deal Size ($mm) $40
 
Underwriters
more
Business Overview
Biotech-focused blank check company backed by Coronado Biosciences.
Biotech-focused blank check company backed by Coronado Biosciences.
more
Company Data
Headquarters Burlington, MA
Founded 2014
Employees
Website www.coronadobiosciences.com
 

Performance vs. IPO Index (IPOUSA)